At Mātai, researchers are developing a new approach to increasing contrast which radically improves visualization of soft tissue contrast.
Research Details
- Ultra-high Contrast MRI (UHC-MRI)
- Gisborne, NZ
- Dr Daniel Cornfled
- research@matai.org.nz
Overview
UHC-MRI is a new MRI technique that provides up to 20 times greater visibility of the brain and shows abnormalities which are not currently visible on conventional MRI. The method uses a mathematical framework for increasing the contrast and sensitivity of MRI. This makes it possible to design sequences that will detect very subtle abnormalities.
Once validated UHC-MRI could be applied to images obtained on any clinical scanners across the globe and could be a game changer for neurological conditions like multiple sclerosis, Alzheimer’s disease, stroke, neuroinflammation, brain tumours, and much more.
UHC-MRI was developed by Emeritus Professor Graeme Bydder, Paul Condron, Mātai team members, and other collaborators.
Gisborne’s Mātai Institute is leading a third wave in medical imaging technology, according to MRI pioneer Graeme Bydder.
It would be no exaggeration to say that the majority of MRIs (Magnetic Resonance Imaging) performed today owe some debt of gratitude to Graeme Bydder.
At Mātai, researchers are developing a new approach to increasing contrast which radically improves visualization of soft tissue contrast.
